Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy-Reference-Cited by-同舟云学术

Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy

Published:2016-12 Issue: Volume:182 Page:111-118
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Grodzinsky Anna,Arnold Suzanne V.,Wang Tracy Y.,Sharma Praneet,Gosch Kensey,Jones Philip G.,Bhatt Deepak L.,Steg Philippe Gabriel,McGuire Darren K.,Cohen David J.,Spertus John A.,Chhatriwalla Adnan K.,Lind Marcus,Graham Garth,Kosiborod Mikhail

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials;Kumbhani;Am Heart J,2008

2. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial;Hermiller;J Am Coll Cardiol,2005

3. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents;Iakovou;JAMA,2005

4. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients;West;Circulation,2004

5. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial;Mathew;Circulation,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Diabetes: A Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2024-01

2. Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry;American Heart Journal;2023-09

3. Risk of bleeding and ischemia in elderly East Asian patients with diabetes mellitus treated with either clopidogrel or ticagrelor: From Korea Acute Myocardial Infarction Registry-V;2023-04-18

4. Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention;Coronary Artery Disease;2022-11-22

5. Questions and answers on the use of aspirin for primary prevention of cardiovascular disease in diabetes;Diabetes Research and Clinical Practice;2022-09